Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Hold
9,814
0.42% 52
2025
Q4
$1.03M Sell
9,814
-700
-7% -$65.7K 0.32% 57
2025
Q3
$882K Sell
10,514
-300
-3% -$24.7K 0.28% 66
2025
Q2
$856K Buy
10,814
+25
+0.2% +$1.99K 0.32% 62
2025
Q1
$968K Buy
10,789
+50
+0.5% +$4.67K 0.41% 54
2024
Q4
$1.07M Sell
10,739
-561
-5% -$57.8K 0.38% 53
2024
Q3
$1.28M Sell
11,300
-1,430
-11% -$170K 0.45% 46
2024
Q2
$1.58M Sell
12,730
-170
-1% -$21.9K 0.57% 38
2024
Q1
$1.7M Sell
12,900
-2,197
-15% -$271K 0.63% 34
2023
Q4
$1.65M Sell
15,097
-444
-3% -$46.1K 0.62% 33
2023
Q3
$1.6M Sell
15,541
-585
-4% -$63.1K 0.79% 22
2023
Q2
$1.86M Sell
16,126
-146
-0.9% -$16.6K 0.82% 19
2023
Q1
$1.73M Sell
16,272
-57
-0.3% -$6.15K 0.89% 20
2022
Q4
$1.81M Sell
16,329
-171
-1% -$17.5K 1.03% 19
2022
Q3
$1.42M Hold
16,500
0.87% 24
2022
Q2
$1.5M Buy
16,500
+118
+0.7% +$10.5K 0.91% 25
2022
Q1
$1.34M Sell
16,382
-72
-0.4% -$5.68K 0.63% 36
2021
Q4
$1.26M Buy
+16,454
New +$1.31M 0.52% 46

Other funds holding MRK

Wealth Effects's MRK Position: Q1 2026 in Review

Wealth Effects held its Merck (MRK) position steady in Q1 2026 at 9,814 shares worth $1.18M. The position accounts for 0.42% of the portfolio, ranked #52.

Wealth Effects first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.86M in Q2 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Wealth Effects held 9,814 shares of Merck worth $1.18M as of Q1 2026.
  • Wealth Effects left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.42% of Wealth Effects's portfolio in Q1 2026, its #52 holding.
  • Wealth Effects first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • Wealth Effects's Merck position peaked at $1.86M in Q2 2023.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.